Form 8-K - Current report:
SEC Accession No. 0001193125-16-765112
Filing Date
2016-11-10
Accepted
2016-11-10 07:04:32
Documents
3
Period of Report
2016-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d287593d8k.htm 8-K 11935
2 EX-99.1 d287593dex991.htm EX-99.1 52882
3 GRAPHIC g287593g35c20.jpg GRAPHIC 4641
  Complete submission text file 0001193125-16-765112.txt   72497
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 161985954
SIC: 2834 Pharmaceutical Preparations